← Leaderboards
Howard D. Beall
University Of Montana
$697,955
Attributed
$697,955
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $173.1K · FY2005–10$200K$150K$100K$50K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$697,955 · 6
By mechanism
P20$682,501 · 5
R15$15,454 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Montana
Same institution · by research overlap
- Walter E Hill$1,746,674
- Charles Thompson$8,271,673
- Andrij Holian$27,802,564
- Christopher Todd Migliaccio$1,734,731
Others in their field
Top investigators on “Enzyme Activity”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Randall J Bateman · Washington University$47,808,754
- Susan Abushakra · Alzheon, Inc.$47,265,244
- David Heimbrook · Leidos Biomedical Research, Inc.$45,964,082
- Stuart L Schreiber · Harvard University (Medical School)$40,631,496
- Keith O Hodgson · Stanford University$37,935,767
Research focus
Enzyme ActivityCell LineNeoplastic CellQuinonesArsenicResearch PersonnelProductionResourcesInstitutionGlutathioneAntineoplastic AntibioticsNonsmall Cell Lung CancerQuinolineNad(P)H DehydrogenaseDrug Screening /EvaluationCho CellsChemical ConjugateCytotoxicityFundingComputer Retrieval Of Information On Scientific Projects DatabaseAtherosclerosisGrantCellsSource
Grant awards (8)
STUDIES ON NOVEL NQO1-DIRECTED QUINOLINEQUINONE ANTITUMOR AGENTS$16,628
P20 · FY2010 · RR · contact PI
MT COBRE: MECHANISM OF CARDIOVASCULAR DISEASE FROM ARSENIC EXPOSURE$173,114
P20 · FY2007 · RR · contact PI
MT COBRE: MECHANISM OF CARDIOVASCULAR DISEASE FROM ARSENIC EXPOSURE$167,500
P20 · FY2006 · RR · contact PI
MT COBRE: MECHANISM OF CARDIOVASCULAR DISEASE FROM ARSENIC EXPOSURE$167,007
P20 · FY2005 · RR
MT COBRE: MECHANISM OF CARDIOVASCULAR DISEASE FROM ARSENIC EXPOSURE$158,252
P20 · FY2004 · RR
MECHANISMS OF CARDIOVASCULAR DISEASE FROM ARSENIC EXPOSURE$0
P20 · FY2002 · RR
ACTIVATION/DETOXICATION STUDIES ON ANTITUMOR QUINONES$6,390
R15 · FY2001 · CA
ACTIVATION/DETOXICATION STUDIES ON ANTITUMOR QUINONES$9,064
R15 · FY2000 · CA